Ayurzen Pharma is headquartered in Hyderabad, India — a leading life-sciences center often called the “Vaccine Hub of India.” Hyderabad’s ecosystem contributes significantly to India’s pharmaceutical output and exports, supporting API supply and specialized dosage forms such as sterile injectables, ophthalmics, and innovative nasal delivery systems under strict GMP-compliant processes. In parallel, we are researching blockchain-based export record systems to reinforce trust and integrity in future shipments; these are not yet in live use.
“To empower global health by delivering innovative, high-quality pharmaceutical ingredients, formulations, and delivery solutions with integrity and scientific excellence.” We also commit to exploring AI and blockchain to uphold integrity and transparency, with all such technologies currently in research/pilot stages.
Ayurzen acts as a trusted integrator in the global pharmaceutical supply chain, managing every step from raw material sourcing to finished-product delivery. We combine deep technical expertise with international partnerships to provide comprehensive solutions. Key offerings include:
High-purity APIs from GMP-certified plants, exported worldwide.
Collaborations with global API manufacturers and CDMOs to scale supply and share innovation, ensuring all partners uphold rigorous quality standards.
Partnerships for sterile injectables, ophthalmics, and advanced nasal delivery systems in state-of-the-art, GMP-aligned facilities.
Assistance in converting APIs into finished products, including formulation development, dosage design, and bioequivalence studies, all under GMP protocols.
End-to-end guidance on regulatory filings (DMFs), GMP certification, and compliance documentation for both APIs and complex formulations.
Developing private/permissioned blockchain prototypes for immutable supply chain visibility is under research/pilot; not in production.
Veeresh Nalkal, Chairman: A seasoned industry leader focused on quality and global reach, with experience across international markets. He promotes a culture of “quality and trust” and encourages research into secure supply chain technologies aligned with evolving global expectations.
Collaboration with Woxsen University integrates AI and pharmaceutical technology education, alongside exploratory research into blockchain-based traceability frameworks to secure supply chain data and enhance compliance readiness; all such work remains research/pilot and not production.
We enforce strict GMP and international quality standards at all stages, and we are pioneering blockchain-enabled tracking to further secure our supply chain.
End-to-end capabilities in APIs, sterile injectables, ophthalmics, and nasal delivery.
GMP compliance underpins every aspect of production, from facility selection to audits and release documentation, ensuring safety and regulatory alignment for international markets. Research into tamper-evident, immutable logging aligns conceptually with robust audit trails but is not currently in live use.
Any references to Blockchain or AI reflect ongoing research/pilot work and are not live production capabilities at this time.